FDA Takes Action: Topical Corticosteroids in Children

[Guest guest]

Dermatology MedPulse®

www.medscape.com/dermatologyhome

MedPulse is a weekly index of key news and features on Medscape's specialty sites compiled by Medscape's Editors.

Instant Certificates: Medscape's CME Certificates are delivered on-line when you complete the activity

Click Here: Medscape CME Center

FROM THE EDITOR

New Regulations?

Topical corticosteroids are among the most ubiquitous drugs in dermatology. While their potential for HPA axis suppression, especially in children, has long been recognized, the issue has resurfaced recently. The Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee recently convened and recommended a risk management plan for topical corticosteroids and their adverse effects on suppression of the HPA-axis in pediatric patients.The Subcommittee also recommended elements of a risk management plan and long-term post marketing studies for the topical immunomodulators pimecrolimus and tacrolimus. You can read about these potential regulatory changes in the just-posted FDA Advisory Committee Reviews.

Best regards,

Editor, Medscape Dermatology

ALSO IN THIS ISSUE:NEWSMEMBER NEWSUSER SUPPORT

NEW FEATURES THIS WEEK

In the Pipeline: FDA Advisory Committee Reviews

The Committee considers a risk management plan for topical corticosteroids and a warning on topical immunomodulators for pediatric patients.AdComm Bulletin 1(10) 2003

Skin Involvement in Dermatomyositis

Dermatomyositis (DM) is a rare multisystem autoimmune disorder that primarily affects skin and skeletal muscle.Curr Opin Rheumatol 15(6) 2003

Nodular Skin Lesions

A 63-year-old woman who had undergone a cadaveric renal transplant 4 months earlier presented with "knots" on both arms and buttocks.Infect Med 20(10) 2003

Recurrent Tingling, Itching Lesions

A 24-year-old woman is referred for evaluation of lesions that have been present on her face for three days.Clinician Reviews 13(9) 2003

WIDESPREAD RESISTANCE TO FIRST-LINE UTI THERAPY

Researchers in Denver, Colorado, are recommending that in their

region at least, trimethoprim-sulfamethoxazole should no longer be

the first-line therapy for uncomplicated urinary tract infection.

Read "Community E. coli Isolates Have High Resistance Rate to Usual First-Line Antibiotic." NEW in the UTI-Zone Resource Center.

NEWS

Topical Bexarotene Gel Effective in Early-Stage Cutaneous T-Cell Lymphoma

Topical bexarotene therapy is effective in patients with refractory or persistent early-stage cutaneous T-cell lymphoma (CTCL), according to a report in the November Journal of the American Academy of Dermatology.

Enfuvirtide Injection Site Reactions Immune-Based

Injection site reactions associated with the use of enfuvirtide for HIV infection are immune-based, according to a report in the November Journal of the American Academy of Dermatology.

Genetic Variation in RUNX1 Binding Sites Linked to Psoriasis, Rheumatoid Arthritis

Genetic polymorphisms in transporter proteins that affect runt-related transcription factor (RUNX1) binding are associated with susceptibility to psoriasis and to rheumatoid arthritis, two research teams report in the December issue of Nature Genetics, published online November 9.

Criminalizing Medical Errors: Does the Punishment Fit the Crime?

Medical mistakes are increasingly being charged as criminal acts; society's changing attitudes may be to blame, according to a BMJ editorial.Medscape Medical News 2003

Pros and Cons of Open-Access Publishing Debated

One article argues that all scientific research should be freely and immediately available online, while a counterpoint article warns that many questions must be answered before open-access publishing can be widely implemented.Medscape Medical News 2003

MEMBER NEWS

COMPREHENSIVE, PRINTABLE DRUG INFORMATION

Medscape DrugInfo provides clinical information on drug indications, adverse effects, interactions, and other cautionary guidance, as well as handouts for your patients. Click DrugInfo from the top of any page, or search by drug name.

Not a member?

Click here to sign up for FREE Medscape membership.

USER SUPPORT

Unsubscribe from this newsletter.

Subscribe to this newsletter.

Forgot your login info?

Cannot read this newsletter? Prefer the TEXT version?

www.medscape.com/px/registration/updateemail

Difficulty linking to a news story?

Need additional support?

..